Chemoinformaics analysis of 21-Acetoxyfriedelan-3-one
| Molecular Weight | 484.765 | nRot | 1 |
| Heavy Atom Molecular Weight | 432.349 | nRig | 28 |
| Exact Molecular Weight | 484.392 | nRing | 5 |
| Solubility: LogS | -6.257 | nHRing | 0 |
| Solubility: LogP | 7.155 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 87 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 90.5192 |
| nHD | 0 | BPOL | 55.6388 |
| QED | 0.354 |
| Synth | 4.98 |
| Natural Product Likeliness | 2.659 |
| NR-PPAR-gamma | 0.042 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.993 |
| Pgp-sub | 0 |
| HIA | 0.037 |
| CACO-2 | -4.943 |
| MDCK | 0.0000136 |
| BBB | 0.086 |
| PPB | 0.929136 |
| VDSS | 1.117 |
| FU | 0.020859 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.294 |
| CYP2c19-inh | 0.044 |
| CYP2c19-sub | 0.937 |
| CYP2c9-inh | 0.135 |
| CYP2c9-sub | 0.053 |
| CYP2d6-inh | 0.035 |
| CYP2d6-sub | 0.105 |
| CYP3a4-inh | 0.662 |
| CYP3a4-sub | 0.66 |
| CL | 8.205 |
| T12 | 0.116 |
| hERG | 0.915 |
| Ames | 0.006 |
| ROA | 0.828 |
| SkinSen | 0.918 |
| Carcinogencity | 0.272 |
| EI | 0.019 |
| Respiratory | 0.957 |
| NR-Aromatase | 0.346 |
| Antiviral | No |
| Prediction | 0.677626 |